drugset / Trial / NCT06821061

A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People

NCT06821061

Phase 1/2 Completed 2650 enrolled BioNTech SE Pfizer · collab
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this study is to learn about how the flu and COVID vaccines act when given alone or when mixed together. This study is seeking healthy participants aged 18 or older. All participants in this study will receive only 1 shot to their arm, either a flu or COVID vaccine, alone or mixed. Participants will take part in this study for about 6 months, and participants will need to visit the clinical study site at least 4 times.

Timeline

Start
2025-02-10
Primary completion
2025-12-17
Completion
2025-12-17

Drugs

EvaluationDrugModalityDoseRoute
Subject Investigational COVID-19 Vaccine Messenger RNA (mRNA)
Subject Investigational Influenza Vaccine Vaccine
Subject Investigational Influenza and COVID-19 Combination Vaccine Messenger RNA (mRNA)
Comparator Licensed COVID-19 Vaccine Vaccine
Comparator Licensed Influenza Vaccine 1 Vaccine
Comparator Licensed Influenza Vaccine 2 Vaccine
Comparator Licensed Influenza Vaccine 3 Vaccine

Indications